Cancer Center of Guangzhou Medical University

Guangzhou, Guangdong 510030

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Lymphoma, Mantle-Cell, Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer — Completed